Hypha Laboratories Establishes Scientific and Cultural Advisory Board, Adds William Padilla-Brown
Hypha Labs (OTCQB:FUNI), a pioneer in functional mushroom sciences, has announced William Padilla-Brown as the inaugural candidate for its new Scientific and Cultural Advisory Board. Padilla-Brown is a renowned citizen scientist, author, and mycology thought leader, known for authoring the first English-language book on Cordyceps cultivation. He is also the founder of MycoFest, a premier event in the mushroom world.
At Hypha Labs, Padilla-Brown will play a critical role in exploring new frontiers in mycology, with a current focus on highlighting the healing properties of North American truffles. His expertise aligns with Hypha Labs' mission to advance decentralized, sustainable, and accessible mycological research. CEO Stone Douglass expressed excitement about Padilla-Brown's addition, emphasizing his valuable contributions to the company's future research and community initiatives.
Hypha Labs (OTCQB:FUNI), un pioniere nelle scienze dei funghi funzionali, ha annunciato William Padilla-Brown come il primo candidato per il suo nuovo Consiglio Scientifico e Culturale. Padilla-Brown è un rinomato scienziato cittadino, autore e leader di pensiero nella micologia, conosciuto per aver scritto il primo libro in inglese sulla coltivazione della Cordyceps. È anche il fondatore di MycoFest, un evento di primo piano nel mondo dei funghi.
Presso Hypha Labs, Padilla-Brown svolgerà un ruolo fondamentale nell'esplorazione di nuove frontiere nella micologia, con un focus attuale sulla valorizzazione delle proprietà curative dei tartufi nordamericani. La sua expertise si allinea con la missione di Hypha Labs di promuovere ricerche micologiche decentralizzate, sostenibili e accessibili. Il CEO Stone Douglass ha espresso entusiasmo per l'aggiunta di Padilla-Brown, sottolineando i suoi preziosi contributi alle future ricerche e iniziative comunitarie dell'azienda.
Hypha Labs (OTCQB:FUNI), un pionero en las ciencias de los hongos funcionales, ha anunciado a William Padilla-Brown como el primer candidato para su nuevo Consejo Asesor Científico y Cultural. Padilla-Brown es un renombrado científico ciudadano, autor y líder de pensamiento en micología, conocido por ser el autor del primer libro en inglés sobre el cultivo de Cordyceps. También es el fundador de MycoFest, un evento de primer nivel en el mundo de los hongos.
En Hypha Labs, Padilla-Brown desempeñará un papel crítico en la exploración de nuevas fronteras en la micología, con un enfoque actual en resaltar las propiedades curativas de las trufas de América del Norte. Su experiencia se alinea con la misión de Hypha Labs de avanzar en la investigación micológica descentralizada, sostenible y accesible. El CEO Stone Douglass expresó su entusiasmo por la incorporación de Padilla-Brown, enfatizando sus valiosas contribuciones a la futura investigación y las iniciativas comunitarias de la empresa.
하이파랩스(Hypha Labs)(OTCQB:FUNI), 기능성 버섯 과학의 선두주자가 William Padilla-Brown을 새로운 과학 및 문화 자문위원회의 첫 번째 후보로 발표했습니다. Padilla-Brown은 시민 과학자이자 저자, 그리고 곰팡이에 대한 사상가로, 코르디셉스 재배에 관한 첫 번째 영문 서적의 저자로 잘 알려져 있습니다. 그는 또한 버섯 세계에서 중요한 행사인 마이코페스트(MycoFest)의 설립자이기도 합니다.
하이파랩스에서 Padilla-Brown은 북미 트뤼플의 치유 특성을 강조하는 데 현재 집중하여 미콜로지의 새로운 경계를 탐험하는 데 중요한 역할을 수행할 것입니다. 그의 전문성은 탈중앙화되고 지속 가능하며 접근 가능한 미콜로지 연구를 발전시키려는 하이파랩스의 사명과 일치합니다. CEO 스톤 더글러스(Stone Douglass)는 Padilla-Brown의 합류에 대한 기대감을 표현하며, 회사의 미래 연구 및 지역 사회 이니셔티브에 대한 그의 귀중한 기여를 강조했습니다.
Hypha Labs (OTCQB:FUNI), un pionnier dans les sciences des champignons fonctionnels, a annoncé William Padilla-Brown comme le premier candidat pour son nouveau Conseil consultatif scientifique et culturel. Padilla-Brown est un scientifique citoyen renommé, auteur et leader d'opinion en mycologie, connu pour avoir écrit le premier livre en anglais sur la culture des Cordyceps. Il est également le fondateur de MycoFest, un événement de premier plan dans le monde des champignons.
Au sein de Hypha Labs, Padilla-Brown jouera un rôle crucial dans l'exploration de nouvelles frontières en mycologie, avec un accent actuel sur la mise en avant des propriétés curatives des truffes nord-américaines. Son expertise s'aligne avec la mission de Hypha Labs de promouvoir une recherche mycologique décentralisée, durable et accessible. Le PDG Stone Douglass a exprimé son enthousiasme concernant l'ajout de Padilla-Brown, soulignant ses précieuses contributions aux recherches futures et aux initiatives communautaires de l'entreprise.
Hypha Labs (OTCQB:FUNI), ein Pionier in der funktionalen Pilz-Wissenschaft, hat William Padilla-Brown als ersten Kandidaten für seinen neuen wissenschaftlichen und kulturellen Beirat angekündigt. Padilla-Brown ist ein renommierter Bürgerwissenschaftler, Autor und Vordenker in der Mykologie, der bekannt ist für die Veröffentlichung des ersten englischsprachigen Buches über die Zucht von Cordyceps. Er ist auch der Gründer von MycoFest, einer bedeutenden Veranstaltung in der Pilzwelt.
Bei Hypha Labs wird Padilla-Brown eine entscheidende Rolle bei der Erforschung neuer Grenzen in der Mykologie spielen, mit einem aktuellen Fokus auf die heilenden Eigenschaften von nordamerikanischen Trüffeln. Seine Expertise stimmt mit der Mission von Hypha Labs überein, dezentrale, nachhaltige und zugängliche mykologische Forschung voranzutreiben. CEO Stone Douglass äußerte seine Begeisterung über die Hinzufügung von Padilla-Brown und betonte dessen wertvolle Beiträge zu den zukünftigen Forschungs- und Gemeinschaftsinitiativen des Unternehmens.
- Addition of renowned mycology expert William Padilla-Brown to the advisory board
- Potential for new research directions, particularly in North American truffles
- Alignment with company's mission for decentralized and accessible mycological research
- Enhanced intellectual capital and diversity of experience
- None.
Board Will Add to Company's Intellectual Capital and Diversity of Experience
LAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce William Padilla-Brown as the inaugural candidate for its Scientific and Cultural Advisory Board. A renowned citizen scientist, author, speaker, and mycology thought leader, Padilla-Brown has continually pushed the boundaries of mycological research and public education, making groundbreaking contributions to the cultivation and understanding of fungi.
Best known for authoring the first English-language book on Cordyceps cultivation, William has shaped how mycologists and enthusiasts alike approach this once-rare mushroom. His book has empowered growers across the globe to explore Cordyceps cultivation, previously a closely-guarded practice. His expertise doesn't stop there; William is a passionate advocate for decentralized research, spearheading the development of independent research facilities for both mycology and algae cultivation.
In addition to his academic contributions, William is the visionary behind MycoFest, a premier event in the mushroom world. MycoFest brings together mycology enthusiasts, researchers, and industry experts for networking, education, fostering collaboration across diverse sectors of the mushroom space. His ability to blend science with community has made him a vital connector in the growing global mycology movement.
At Hypha Labs, William's role will be critical as the Company explores new frontiers in mycology. His current focus includes highlighting the healing properties of truffles native to North America, bringing much-needed attention to their health and wellness benefits. His insights into this relatively untapped resource will guide future research at Hypha Labs, with the goal of broadening public awareness of these potent fungi.
"We're incredibly excited to have William Padilla-Brown joining us on this journey," said Stone Douglass, CEO at Hypha Labs. "His work aligns perfectly with our mission to advance decentralized, sustainable, and accessible mycological research. His expertise and passion for fungi will be invaluable as we continue to push the boundaries of what is possible in this field."
As Hypha Labs continues its mission to innovate in the world of mycology, William's leadership will be instrumental in shaping our research agenda and community initiatives. His unique blend of hands-on experience, scientific rigor, and community engagement is a perfect match for Hypha Labs' vision of a more connected, informed, and empowered mycological future.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD LOOKING STATEMENTS:
This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity MediaInc.
(888) 216-3595
team@integritymedia.com
Contact Information
Kurt Divich
President, Integrity Media Inc.
team@integritymedia.com
(888) 216-3595
SOURCE: Hypha Labs
View the original press release on accesswire.com
FAQ
Who is William Padilla-Brown and why is he joining Hypha Labs (OTCQB:FUNI)?
What is William Padilla-Brown's most significant contribution to mycology?
What will be William Padilla-Brown's focus at Hypha Labs (OTCQB:FUNI)?
How does William Padilla-Brown's expertise align with Hypha Labs' (OTCQB:FUNI) mission?
